WARNING: This product contains non-tobacco-derived nicotine. Nicotine is an addictive chemical.

Committed to a Better Future without Cigarettes

We use research and science to develop a treatment that helps millions of people quit cigarettes, improving public health through the gradual eradication of nicotine addiction.

Kaival Labs - COMMITTED TO A BETTER FUTURE WITHOUT CIGARETTES

The Science Behind Nicotine Addiction Treatment


Nicotine Addiction is a public health concern that we are persistent in solving.

Kaival Labs is awarded a cessation patent for innovating treatments for nicotine addiction. By modifying the R- and S- isomer ratios of nicotine, we can use non-addictive synthetic nicotine to develop smoking cessation products.

THE SCIENCE BEHIND NICOTINE ADDICTION TREATMENT

Patent for Forward-Thinking
Formulation

Kaival Labs is a powerhouse for developing smoking cessation products, which allow us to provide them with synthetic nicotine with 99.5% purity using our patented R-S-isomers formulation.

We can fuel the future we want to see through our innovations and synthetic nicotine formulation, which is substantially free from carcinogenic compounds.

INNOVATION

COMMITMENT

Kaival Labs Innovation
shield

Developing a synthesis of pharmaceutically, pure,

USP grade, (R,S)-nicotine applicable for industrial-scale preparation and commercially viable.

Learn more >

  • Kaival Labs Innovation

    • Developing a synthesis of pharmaceutically pure, USP grade, (R, S)-nicotine applicable for industrial-scale preparation and commercially viable
    • Developing a method for synthesis of the pure nicotine without most of, or any other, non-nicotine moieties commonly found in tobacco-derived nicotine
    • Developing (R, S)-nicotine preparations that are greater than 99.5% pure, which meet or surpass the purity requirements described for nicotine in the USA USP monograph
    • Developing a synthetic route to (R, S)-nicotine that uses starting materials that are readily available worldwide in large quantities
    • Providing a competitive pricing strategy for wholesale marketplace versus tobacco-derived nicotine
     Kaival Labs Innovation
  • Kaival Labs Commitment

    Premium Quality Raw Materials

    • All raw materials are sourced from accredited suppliers to ensure safety and quality.

    Secure, High-Tech Facility

    • Our dedicated facility is innovated to cater to our patented manufacturing.

    Certified Processes

    • All processes and our facility are cGMP and ISO certified.

    Quality Assurance and Strict Monitoring

    • Every product is assessed and monitored thoroughly.

    Pure Synthetic Nicotine

    • Synthetic nicotine without the impurities from tobacco.
    Kaival Labs Commitment
Leading with a Vision

Leading with a Vision

 “Innovation is an attempt to solve the problem. We have been part of the industry long enough to be imperative in addressing tobacco nicotine addiction. Imagine a future without tobacco nicotine? What do you see? To us, it’s a more sustainable world with an improved quality of life, especially to those who are exposed to cigarettes and tobacco products. We want to take part in achieving this vision.”

— Niraj Patel, CEO of Kaival Labs

 

WE’RE BETTER TOGETHER

PARTNER WITH US

The long list of studies and records that prove the harmful effects of tobacco consumption will continue to drive the market to use premium smoking cessation products from Kaival Labs. Lessening the use of cigarettes and tobacco can impact human health.

Imagine a world without tobacco nicotine addiction—that’s where we want to be! Do you want to join us?

INVEST IN THE FUTURE

The smoking cessation market is projected to reach $63.99 billion by 2026, growing at a CAGR of 16.9% from 2018 to 2026. This implies that our R-S-Nicotine patent is the future of the nicotine-related industry. Premium nicotine products free from tobacco from Kaival Labs plays a significant role in this projection.

Kaival Labs commits to an improved lifestyle for cigarette smokers, dedicating our efforts to a better future.